Physician profile
Mike Martinez
NPI 1043534662
$3,324.41
in general payments reported to CMS, 2019-2025
13 companies · $101 in 2025
The $101 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $577 · 2020: $491 · 2021: $1,031 · 2022: $830 · 2023: $172 · 2024: $122 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $381 · Travel and Lodging: $13.91.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $380.82 |
| Travel and Lodging | $13.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,537.55 | 2021-2024 | Wavewriter Alpha Prime 16, Avvigo Guidance System |
| Nevro Corp. | $870.34 | 2019-2023 | Senza |
| Abbott Laboratories | $342.78 | 2020-2024 | Eterna |
| Pfizer INC. | $190.03 | 2020-2021 | |
| Medtronic, INC. | $166.51 | 2021-2025 | Azure Xt Dr Mri Surescan, Aurora Ev-Icd Mri Surescan, Tyrx |
| Medtronic USA, INC. | $50.19 | 2019-2020 | |
| Saluda Medical Americas, INC. | $29.98 | 2025 | Evoke |
| Spinal Simplicity, LLC | $26.16 | 2020-2024 | Ha Minuteman G3-R |
| Baudax Bio INC. | $24.70 | 2021 | |
| Biotronik Nro, INC. | $24.57 | 2025 | Prospera |
| Scilex Pharmaceuticals INC. | $22.78 | 2022 | |
| Janssen Pharmaceuticals, INC | $21.48 | 2020 | |
| Collegium Pharmaceutical, INC. | $17.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mike Martinez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.